Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice

Human Molecular Genetics

Volumn 11, Issue 16, 2002, Pages 1855-1863

  Haston, Christina K ^a   Wang, Min ^a   Dejournett, Robert E ^a   Zhou, Xinhui ^a   Ni, Dan ^a   Gu, Xiangjun ^a   King, Terri M ^a   Weil, Michael M ^a   Newman, Robert A ^a   Amos, Christopher I ^a   Travis, Elizabeth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN HYDROLASE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEINASE; ANTINEOPLASTIC ANTIBIOTIC; CYSTEINE PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME SUBSTITUTION; CONGENIC STRAIN; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; LUNG FIBROSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; SEX DIFFERENCE; ANIMAL; BIOLOGICAL MODEL; C3H MOUSE; C57BL MOUSE; CHROMOSOME MAP; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; RISK FACTOR; SEXUAL DEVELOPMENT;

ANIMALIA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CHROMOSOME MAPPING; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, CONGENIC; MICE, INBRED C3H; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PHENOTYPE; PULMONARY FIBROSIS; RISK FACTORS; SEX CHARACTERISTICS;

EID: 0036667985     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.16.1855     Document Type: Article

References (41)

1. Genetic susceptibility to ozone exposure
2. Genetic linkage analysis of susceptibility to particle exposure in mice
3. Pulmonary morbidity 10-18 years after irradiation for Hodgkin's disease
4. Radiation pneumonitis in patients treated for breast cancer
5. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future
6. Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients
7. Early clinical experience with bleomycin in the United Kingdom in series of 105 patients
8. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?
9. Is there a fibrotic gene?
10. The pathogenesis of pulmonary fibrosis: Is there a fibrosis gene?
11. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes
12. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse
13. Different sensitivity to bleomycin-induced pulmonary fibrosis among various strains of mice
14. A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma
15. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis
16. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice
17. Association of malignancy with diseases causing interstitial pulmonary changes
18. Complexity of lung cancer modifiers: Mapping of thirty genes and twenty-five interactions in half of the mouse genome
19. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps
20. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57B1/6J mice
21. Analysing complex genetic traits with chromosome substitution strains
22. Genotype selection to rapidly breed congenic strains
23. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice
24. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis
25. Immunogenetic analysis of silicosis in Japan
26. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis
27. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice
28. Two new proteases in the MHC class I processing pathway
29. Cutting edge: Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation
30. Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling
31. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis
32. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance
33. Transgenic mice expressing the Sh ble bleomycin resistance gene are protected against bleomycin-induced pulmonary fibrosis
34. A genetic map of the mouse with 4,006 simple sequence length polymorphisms
35. MapManager, a Macintosh program for storage and analysis of experimental genetic mapping data
36. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
37. Empirical threshold values for quantitative trait mapping
38. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity